Measurement of the Structural Efficacy in Active Rheumatoid Arthritis (RA) Patients Treated With Sarilumab in Combination With Methotrexate (MTX) and Naive to Biologics as Measured by Low-field MRI Using a Modified OMERACT-RAMRIS Score.
Phase of Trial: Phase III
Latest Information Update: 08 Jul 2019
Price : $35 *
At a glance
- Drugs Sarilumab (Primary) ; Methotrexate; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 02 Jul 2019 Planned End Date changed from 30 Jul 2020 to 30 Dec 2020.
- 05 Jun 2018 Status changed from not yet recruiting to recruiting.
- 29 May 2018 New trial record